Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2008;9(3):836-9.
doi: 10.1208/s12249-008-9120-2. Epub 2008 Jul 15.

Design and evaluation of a sustained release gastroretentive dosage form of captopril: a technical note

P Patel  1 , N Dand, A Somwanshi, V J Kadam, R S Hirlekar
Affiliations
Comparative Study

Design and evaluation of a sustained release gastroretentive dosage form of captopril: a technical note

P Patel et al. AAPS PharmSciTech. 2008.
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Comparison of in vitro drug release profiles of floating formulations of CAP
Fig. 2
Fig. 2
Effect of % RH on weight gain by optimized formulation of CAP
See this image and copyright information in PMC

References

    1. Sheth P. R., Tossounian J. L. The hydrodynamic balanced system (HBS): a novel drug delivery system for oral use. Drug Dev. Ind. Pharm. 1984;10:339. doi: 10.3109/03639048409064653. - DOI
    1. Chien Y. E. Potential developments, new approaches in oral controlled release drug delivery systems. Drug Dev. Ind. Pharm. 1993;9:486–488.
    1. Deshpande A. A., Rhodes C. T., Shah N. H., Malick A. W. Controlled release drug delivery systems for prolonged gastric residence: an overview. Drug Dev. Ind. Pharm. 1996;22:531–539. doi: 10.3109/03639049609108355. - DOI
    1. Uzdemir N., Ordu S., Ozkan Y. Studies of floating dosage forms of furosemide: in vitro and in vivo evaluation of bilayer tablet formulations. Drug Dev. Ind. Pharm. 2000;26:857–866. doi: 10.1081/DDC-100101309. - DOI - PubMed
    1. Ingani H. M., Timmermans J., Moes A. J. Conception and in vivo investigation of peroral sustained release floating dosage forms with enhanced gastrointestinal transit. Int. J. Pharm. 1987;35:157–164. doi: 10.1016/0378-5173(87)90084-6. - DOI

Publication types

MeSH terms